Showcase its Differentiated CNS Clinical Candidates - Suven Life Sciences Ltd

Code BSE: 530239 NSE: $SUVEN Suven Life Sciences to showcase its Differentiated CNS Clinical Candidates and Partnering Strategies at BIO International Convention 2026, 22-25, June 2026, San Diego, USA Suven Life Sciences will welcome the Delegates, Investors, and Potential Partners & collaborators from Big Pharma, Biotech companies to Booth # 6154, where the company will showcase its Differentiated CNS portfolio, including late-stage clinical assets targeting significant unmet medical needs in indications like Agitation in Dementia of Alzheimer's Type, Major Depressive Disorder, Narcolepsy, Cognitive Impairment associated with Parkinson's disease and other CNS disorders.